glp-1 cancer risk No Increased for Thyroid in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin GLP-1 Agents vs Aspirin: A

December 2024: Merck & Co

Methods Design This was a qualitative study using individual semi-structured interviews

& Holscher, C

A synergic GLP-1/Acylethanolamide-based combined therapy for MAFLD: studies in rat models

Both the 2016 consensus statement of the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) on management of type 2 diabetes and the 2016 American Diabetes Association (ADA) standards recommend adding on GLP-1 RAs to patients not meeting treatment goals with basal insulin

GLP-1 (glucagon-like peptide-1) drugs, such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), have shown some weight loss and cardiometabolic benefits in clinical trials